Literature DB >> 22563607

Substantial multiclass transmitted drug resistance and drug-relevant polymorphisms among treatment-naïve behaviorally HIV-infected youth.

Allison L Agwu, James Bethel, Lisa B Hightow-Weidman, John W Sleasman, Craig M Wilson, Bret Rudy, Bill G Kapogiannis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22563607      PMCID： PMC3317397          DOI： 10.1089/apc.2011.0420

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN： 1087-2914            Impact factor:   5.078


× No keyword cloud information.
  11 in total

Review 1.  Rates of transmission of antiretroviral drug resistant strains of HIV-1.

Authors:  Palanee Ammaranond; Philip Cunningham; Robert Oelrichs; Kazuo Suzuki; Claire Harris; Leakhena Leas; Andrew Grulich; David A Cooper; Anthony D Kelleher
Journal:  J Clin Virol       Date:  2003-02       Impact factor: 3.168

2.  Transmitted HIV-1 drug resistance among young men of color who have sex with men: a multicenter cohort analysis.

Authors:  Lisa B Hightow-Weidman; Christopher B Hurt; Gregory Phillips; Karen Jones; Manya Magnus; Thomas P Giordano; Angulique Outlaw; Daniel Ramos; Elizabeth Enriquez-Bruce; Will Cobbs; Amy Wohl; Melinda Tinsle
Journal:  J Adolesc Health       Date:  2010-08-24       Impact factor: 5.012

3.  Prevalence of primary HIV-1 drug resistance among recently infected adolescents: a multicenter adolescent medicine trials network for HIV/AIDS interventions study.

Authors:  Rolando M Viani; Ligia Peralta; Grace Aldrovandi; Bill G Kapogiannis; Rick Mitchell; Stephen A Spector; Yolanda S Lie; Jodi M Weidler; Michael P Bates; Nancy Liu; Craig M Wilson
Journal:  J Infect Dis       Date:  2006-10-20       Impact factor: 5.226

4.  Primary drug resistance in antiretroviral-naïve injection drug users.

Authors:  Harout K Tossonian; Jesse D Raffa; Jason Grebely; Mark Viljoen; Annabel Mead; Milan Khara; Mark McLean; Ashok Krishnamurthy; Stanley DeVlaming; Brian Conway
Journal:  Int J Infect Dis       Date:  2008-12-25       Impact factor: 3.623

Review 5.  Update of the drug resistance mutations in HIV-1: December 2010.

Authors:  Victoria A Johnson; Françoise Brun-Vézinet; Bonaventura Clotet; Huldrych F Günthard; Daniel R Kuritzkes; Deenan Pillay; Jonathan M Schapiro; Douglas D Richman
Journal:  Top HIV Med       Date:  2010-12

6.  Youth-specific considerations in the development of preexposure prophylaxis, microbicide, and vaccine research trials.

Authors:  Bret J Rudy; Bill G Kapogiannis; Michelle A Lally; Glenda E Gray; Linda-Gail Bekker; Paul Krogstad; Ian McGowan
Journal:  J Acquir Immune Defic Syndr       Date:  2010-07       Impact factor: 3.731

7.  Prevalence of sexually acquired antiretroviral drug resistance in a community sample of HIV-positive men who have sex with men in New York City.

Authors:  Lloyd A Goldsamt; Michael C Clatts; Monica M Parker; Vivian Colon; Renee Hallack; Maria G Messina
Journal:  AIDS Patient Care STDS       Date:  2011-04-02       Impact factor: 5.078

8.  Behavioral health risks in perinatally HIV-exposed youth: co-occurrence of sexual and drug use behavior, mental health problems, and nonadherence to antiretroviral treatment.

Authors:  Claude A Mellins; Katherine Tassiopoulos; Kathleen Malee; Anna-Barbara Moscicki; Doyle Patton; Renee Smith; Ann Usitalo; Susannah M Allison; Russell Van Dyke; George R Seage
Journal:  AIDS Patient Care STDS       Date:  2011-05-05       Impact factor: 5.078

9.  Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population.

Authors:  Andrew J Leigh Brown; Simon D W Frost; W Christopher Mathews; Keith Dawson; Nicholas S Hellmann; Eric S Daar; Douglas D Richman; Susan J Little
Journal:  J Infect Dis       Date:  2003-01-29       Impact factor: 5.226

10.  Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update.

Authors:  Diane E Bennett; Ricardo J Camacho; Dan Otelea; Daniel R Kuritzkes; Hervé Fleury; Mark Kiuchi; Walid Heneine; Rami Kantor; Michael R Jordan; Jonathan M Schapiro; Anne-Mieke Vandamme; Paul Sandstrom; Charles A B Boucher; David van de Vijver; Soo-Yon Rhee; Tommy F Liu; Deenan Pillay; Robert W Shafer
Journal:  PLoS One       Date:  2009-03-06       Impact factor: 3.240
View more
  12 in total

Review 1.  The adolescent and young adult HIV cascade of care in the United States: exaggerated health disparities.

Authors:  Brian C Zanoni; Kenneth H Mayer
Journal:  AIDS Patient Care STDS       Date:  2014-03       Impact factor: 5.078

2.  Ten years survey of primary HIV-1 resistance in Serbia: the occurrence of multiclass resistance.

Authors:  Maja Stanojevic; Marina Siljic; Dubravka Salemovic; Ivana Pesic-Pavlovic; Sonja Zerjav; Valentina Nikolic; Jovan Ranin; Djordje Jevtovic
Journal:  AIDS Res Hum Retroviruses       Date:  2014-04-09       Impact factor: 2.205

3.  Association of Risk of Viremia, Immunosuppression, Serious Clinical Events, and Mortality With Increasing Age in Perinatally Human Immunodeficiency Virus-Infected Youth.

Authors:  Anne M Neilan; Brad Karalius; Kunjal Patel; Russell B Van Dyke; Mark J Abzug; Allison L Agwu; Paige L Williams; Murli Purswani; Deborah Kacanek; James M Oleske; Sandra K Burchett; Andrew Wiznia; Miriam Chernoff; George R Seage; Andrea L Ciaranello
Journal:  JAMA Pediatr       Date:  2017-05-01       Impact factor: 16.193

4.  Global HIV-1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

Authors:  J D Baxter; D Dunn; E White; S Sharma; A M Geretti; M J Kozal; M A Johnson; S Jacoby; J M Llibre; J Lundgren
Journal:  HIV Med       Date:  2015-04       Impact factor: 3.180

5.  A multicenter study of initiation of antiretroviral therapy and transmitted drug resistance in antiretroviral-naive adolescents and young adults with HIV in New York City.

Authors:  Christina Gagliardo; Ava Brozovich; Jeffrey Birnbaum; Anita Radix; Marc Foca; John Nelson; Lisa Saiman; Michael Yin; Elektra Carras-Terzian; Emily West; Natalie Neu
Journal:  Clin Infect Dis       Date:  2014-01-14       Impact factor: 9.079

6.  Antiretroviral treatment initiation does not differentially alter neurocognitive functioning over time in youth with behaviorally acquired HIV.

Authors:  Sharon L Nichols; James Bethel; Bill G Kapogiannis; Tiandong Li; Steven P Woods; E Doyle Patton; Weijia Ren; Sarah E Thornton; Hanna O Major-Wilson; Ana M Puga; John W Sleasman; Bret J Rudy; Craig M Wilson; Patricia A Garvie
Journal:  J Neurovirol       Date:  2015-10-13       Impact factor: 2.643

Review 7.  The case for viral load testing in adolescents in resource-limited settings.

Authors:  Rebecca Marcus; Rashida A Ferrand; Katharina Kranzer; Linda-Gail Bekker
Journal:  J Int AIDS Soc       Date:  2017-11       Impact factor: 5.396

8.  Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States.

Authors:  Lisa L Ross; Denise Shortino; Mark S Shaefer
Journal:  AIDS Res Hum Retroviruses       Date:  2018-06-05       Impact factor: 2.205

9.  Modeling Adherence Interventions Among Youth with HIV in the United States: Clinical and Economic Projections.

Authors:  Anne M Neilan; Audrey C Bangs; Michael Hudgens; Kunjal Patel; Allison L Agwu; Ingrid V Bassett; Aditya H Gaur; Emily P Hyle; Catherine M Crespi; Keith J Horvath; Caitlin M Dugdale; Kimberly A Powers; H Jonathon Rendina; Milton C Weinstein; Rochelle P Walensky; Kenneth A Freedberg; Andrea L Ciaranello
Journal:  AIDS Behav       Date:  2021-02-06

Review 10.  Antiretroviral treatment, management challenges and outcomes in perinatally HIV-infected adolescents.

Authors:  Allison L Agwu; Lee Fairlie
Journal:  J Int AIDS Soc       Date:  2013-06-18       Impact factor: 5.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.